1-(Benzo[d]thiazol-2-ylsulfonyl)piperidine-4-carboxylic acid

Catalog No. :
ACVGUN630
CAS No. :
1411766-33-0
Molecular Formula :
C13H14N2O4S2
Molecular Weight :
326.40

IUPAC Name:1-(benzo[d]thiazol-2-ylsulfonyl)piperidine-4-carboxylic acid

1-(Benzo[d]thiazol-2-ylsulfonyl)piperidine-4-carboxylic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg97%$87.00Login to see priceIn stockInquiry
250mg97%$145.00Login to see priceIn stockInquiry
1g97%$390.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(Benzo[d]thiazol-2-ylsulfonyl)piperidine-4-carboxylic acid
IUPAC Name1-(benzo[d]thiazol-2-ylsulfonyl)piperidine-4-carboxylic acid
MDL No.MFCD22574906
Molecular FormulaC13H14N2O4S2
Molecular Weight326.40
SMILESO=C(C1CCN(S(=O)(C2=NC3=CC=CC=C3S2)=O)CC1)O
InChI KeyAMGKRFSJEGYUPP-UHFFFAOYSA-N
Synonym1-(Benzothiazole-2-sulfonyl)-piperidine-4-carboxylic acid;4-Piperidinecarboxylic acid, 1-(2-benzothiazolylsulfonyl)-;1-(Benzo[d]thiazol-2-ylsulfonyl)piperidine-4-carboxylic acid
CAS No.1411766-33-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319
Precautionary Statement(s)
P264-P270-P280-P301+P312+P330-P302+P352-P305+P351+P338-P332+P313-P337+P313-P362+P364-P501

Synthetic Route by SureRoute

1. ACVGUN630 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVGUN630 route product structure diagram
    ACVGUN6301411766-33-0 In Stock
Inquiry

2. ACVGUN630 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACIWFN675 route compound structure diagram
    ACIWFN6755984-56-5 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACVGUN630 route product structure diagram
    ACVGUN6301411766-33-0 In Stock
Inquiry

Comments (0)